Clinical trials - Press Releases

Date	Title	Company
31-May-2023	Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b	Coave Therapeutics
31-May-2023	Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials	Lotus Clinical Research
31-May-2023	Cmed and Larix fully integrated into Aixial Group, the CRO solution of ALTEN Group	Aixial Group
31-May-2023	Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis	Sanofi
31-May-2023	Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients	Avance Clinical
30-May-2023	Parkinson’s AI proves accuracy in clinical studies	PD Neurotechnology
30-May-2023	MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular Dystrophy	MetrioPharm AG
30-May-2023	selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis	selectION, Inc.
26-May-2023	Avance Clinical Joins Global Heath Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies	Avance Clinical
25-May-2023	Antabio Announces First Subjects Dosed in Phase 1 Clinical Trial of MEM-ANT3310, a Highly Differentiated Antibiotic for Severe Hospital Infections	Antabio
25-May-2023	CellProthera enters final recruitment stage for phase I/IIb post-myocardial infarction therapy study	CellProthera
24-May-2023	Immutep announces promising new clinical data from triple combination therapy in INSIGHT-003 trial	Immutep
24-May-2023	ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002	ImmunOs Therapeutics
24-May-2023	Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001	Thermosome GmbH
23-May-2023	Promising Phase 1 results for antibody NI006 in ATTR cardiomyopathy published in The New England Journal of Medicine	Neurimmune
23-May-2023	Two thirds of Brits would take part in a clinical trial to help discover new treatments - but financial payment is key	Lindus Health
18-May-2023	Kynos Therapeutics announces a first-in-human Phase I study of its novel small molecule KMO inhibitor, KNS366, is underway	Kynos Therapeutics
18-May-2023	Primary Results of the Phase 1b Proof-of-Concept Study of NI006 to be presented at the ESC Heart Failure Congress 2023	Neurimmune
16-May-2023	ABBOTT ANNOUNCES NEW PARTNERSHIPS AND PROGRAMS TO ADVANCE ITS DIVERSITY IN CLINICAL TRIALS INITIATIVE	ABBOTT
12-May-2023	Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting	Sanofi